💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
Profile for Transgenomic, Inc. (TBIO)
« Back to company indexTBIO Chatter Timeline
Stock Ticker for TBIO
Most Active Tweeters for TBIO
| User | Tweets |
|---|---|
| @FlashAlert_me | 7 |
| @InsiderAlerts4U | 6 |
| @Tickeron | 5 |
| @newsfilterio | 5 |
| @Gambiste1 | 3 |
Recent Tweets for TBIO
 |
@Tickeron $TBIO in Downtrend: RSI indicator exits overbought zone. View odds for this and other indicators:… https://t.co/VBuftbAAKW June 21st 2021, 10:06pm |
 |
@TradeWithAlerts Large Print $TBIO Size: 120,000 Price: 18.5 Time: 1127 Amount: $2,220,000.00 - Delayed - For real time prints subsc… https://t.co/vCb9RvHXhY June 21st 2021, 3:06pm |
 |
@OxAnalyst @JamesEKrause $TBIO $SNY MRT5500 as well https://t.co/FzVZO4w8FD June 21st 2021, 11:06am |
 |
@Gambiste1 RT @suma987: @RNAiAnalyst I think we can now say unmodified mRNA vaccines are not as efficient as modified ones. waiting for $Tbio ‘s resul… June 19th 2021, 5:06pm |
 |
@tradersreport RT @Tickeron: $TBIO in Downtrend: RSI indicator exits overbought zone. View odds for this and other indicators: https://t.co/Fpalifxh4U #Tr… June 19th 2021, 9:06am |
|
@Tickeron $TBIO in Downtrend: RSI indicator exits overbought zone. View odds for this and other indicators:… https://t.co/ohsPSzthFN June 19th 2021, 9:06am |
 |
@newsfilterio 20,000 shares acquired by Formela Jean Francois (Director), reported in a new form 4 filed with the SEC $TBIO https://t.co/jQefs4OZVd June 19th 2021, 1:06am |
 |
@shortablestocks $TBIO is short sale restricted for 2021-06-18. https://t.co/tIMfG2RQh5 June 18th 2021, 1:06pm |
 |
@InsiderAlerts4U $TBIO: New Insider Filing on Translate Bio, Inc.'s Director JEAN FRANCOIS FORMELA: https://t.co/MXz9NkCR1B June 18th 2021, 11:06am |
 |
@FlashAlert_me $TBIO [15s. delayed] filed SEC form 4: Director FORMELA JEAN FRANCOIS: Transacted Derivative Securities on 2021-06… https://t.co/NyTjK8uRu5 June 18th 2021, 1:06am |
|
@Gambiste1 RT @ShortAlgoTrades: $TBIO Now awaiting Buy signal. Got to love the UltraAlgo for beating the pump and dump game! https://t.co/wdBbXFDjDb June 17th 2021, 7:06pm |
 |
@ShortAlgoTrades $TBIO Now awaiting Buy signal. Got to love the UltraAlgo for beating the pump and dump game! https://t.co/wdBbXFDjDb June 17th 2021, 7:06pm |
 |
@EZMoney_41 $TBIO Now awaiting Buy signal. https://t.co/x8x597Fdud June 17th 2021, 7:06pm |
|
@InsiderAlerts4U $TBIO: New Insider Filing on Translate Bio, Inc.'s Director GEORGE DEMETRI: https://t.co/VkUdyzEDwh June 17th 2021, 8:06am |
|
@InsiderAlerts4U $TBIO: New Insider Filing on Translate Bio, Inc.'s Director ROBERT M PLENGE: https://t.co/tM0rMYREr1 June 17th 2021, 7:06am |
 |
@GuptaBioDD @adamfeuerstein @GZuckerman $TBIO also on sidelines not working June 17th 2021, 6:06am |
|
@GuptaBioDD @dax50 @RNAiAnalyst Look at $TBIO for what an mRNA company with no future prospects or revenue is worth June 17th 2021, 6:06am |
|
@InsiderAlerts4U $TBIO: New Insider Filing on Translate Bio, Inc.'s Director OWEN HUGHES: https://t.co/dteLbJIwom June 17th 2021, 1:06am |
|
@InsiderAlerts4U $TBIO: New Insider Filing on Translate Bio, Inc.'s Director ROBERT J. MEYER: https://t.co/BGg1RAO4gi June 16th 2021, 11:06pm |
|
@InsiderAlerts4U $TBIO: New Insider Filing on Translate Bio, Inc.'s Director DANIELLA BECKMAN: https://t.co/OyBkOlvMPd June 16th 2021, 10:06pm |
|
@Gambiste1 RT @malojoeyy: @RNAiAnalyst Any thoughts on $TBIO at this point? June 16th 2021, 9:06pm |
 |
@malojoeyy @RNAiAnalyst Any thoughts on $TBIO at this point? June 16th 2021, 9:06pm |
|
@newsfilterio 20,000 shares acquired by Plenge Robert M (Director), reported in a new form 4 filed with the SEC $TBIO https://t.co/lSk6Mmxn65 June 16th 2021, 9:06pm |
|
@FlashAlert_me $TBIO [15s. delayed] filed SEC form 4: Director Beckman Daniella: Transacted Derivative Securities on 2021-06-16. https://t.co/nc6FTgUHCF June 16th 2021, 9:06pm |
|
@FlashAlert_me $TBIO [15s. delayed] filed SEC form 4: Director Meyer Robert J.: Transacted Derivative Securities on 2021-06-16. https://t.co/jmiVWtZ7bd June 16th 2021, 9:06pm |
|
@FlashAlert_me $TBIO [15s. delayed] filed SEC form 4: Director Plenge Robert M: Transacted Derivative Securities on 2021-06-16. https://t.co/C7HsKjahmj June 16th 2021, 9:06pm |
|
@FlashAlert_me $TBIO [15s. delayed] filed SEC form 4: Director Hughes Owen: Transacted Derivative Securities on 2021-06-16. https://t.co/5FbVJaQ6xK June 16th 2021, 9:06pm |
|
@FlashAlert_me $TBIO [15s. delayed] filed SEC form 4: Director Demetri George: Transacted Derivative Securities on 2021-06-16. https://t.co/HS77Lrw4vB June 16th 2021, 9:06pm |
 |
@EdgarInsider SEC Form 8-K [Press/News Current Report] filed by $TBIO Translate Bio, Inc https://t.co/i5DIfMczhI June 16th 2021, 8:06pm |
 |
@investor_feed $TBIO 8-K Translate Bio (16 Jun, 4:48pm) ? Departure of Directors or Certain Officers; Election of Directors… https://t.co/SCTXlcFDxZ June 16th 2021, 8:06pm |
|
@FlashAlert_me $TBIO [15s. delayed] filed form 8-K on June 16, 16:48:30 https://t.co/BbBVSqwklW June 16th 2021, 8:06pm |
 |
@ElsayadAbdallah 5-min chart of $TBIO. Trend is telling with the UltraAlgo #StockMarket #stocks #stockstowatch #Stock Get a free tri… https://t.co/ekN5ebAm7N June 16th 2021, 7:06pm |
|
@newsfilterio TRANSLATE BIO - Appeal, Reversed $TBIO https://t.co/vSj2KSDFm4 June 16th 2021, 4:06pm |
|
@Tickeron $TBIO enters an Uptrend because Momentum Indicator exceeded the 0 level on May 26, 2021. View odds for this and oth… https://t.co/aieIjVhAnl June 15th 2021, 2:06am |
 |
@trademarktrader This logo is being trademarked by Translate Bio, Inc. https://t.co/KLuBU39mTJ # $TBIO https://t.co/2OJXndWvH3 June 15th 2021, 1:06am |
|
@Tickeron $TBIO enters an Uptrend as Momentum Indicator exceeded the 0 level on May 26, 2021. View odds for this and other in… https://t.co/GGJB2ub2Ha June 14th 2021, 3:06am |
|
@Tickeron $TBIO in Uptrend: RSI indicator exits oversold zone. View odds for this and other indicators:… https://t.co/TouPueT1ek June 10th 2021, 3:06am |
 |
@PMDiChristina $TBIO looks back https://t.co/ye8cMzXSwd June 10th 2021, 3:06am |
|
@newsfilterio Translate Bio Reports Inducement Grants under Nasdaq Listing Rule 5635 $TBIO https://t.co/51hROBOqfl June 9th 2021, 11:06pm |
 |
@ObsidoR #investing idea. Short $TBIO @TranslateBio. The MRT platform is one huge scam. That’s why Takeda sold out, sooner o… https://t.co/4XSLsqqYaY June 9th 2021, 10:06pm |
 |
@otcdynamics $TBIO Translate Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) https://t.co/h8sXh7Urcs June 9th 2021, 8:06pm |
 |
@StockNewsBot2 $TBIO Translate Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) https://t.co/TSfwPB2nup June 9th 2021, 8:06pm |
 |
@kevinjaybe $TBIO Translate Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) https://t.co/e2Vq6W7DRh June 9th 2021, 8:06pm |
 |
@stock_titan $TBIO Translate Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) https://t.co/i37nZFfS1v June 9th 2021, 8:06pm |
|
@ObsidoR Selling $TBIO / $CVAC and going long puts several August strikes. @sanofi will do so too. TBIO will have a hard tim… https://t.co/4rNcmvS3e0 June 9th 2021, 1:06pm |
 |
@Raylstation $TBIO Up 9/10 days https://t.co/uXMaSaYVZm https://t.co/Dw4d3fbUmP June 9th 2021, 1:06pm |
 |
@XBIObserver @Sys2Research Yet they have plowed ahead with $GSK in partnership and $TBIO for a mRNA deal June 8th 2021, 9:06pm |
|
@ElsayadAbdallah Signals could not be any clearer on the 5-minute chart of $TBIO #StockMarket #stocks #stockstowatch #Stock #TBIO https://t.co/IF6DNDbBJv June 8th 2021, 12:06pm |
|
@newsfilterio Translate Bio Achieves Manufacturing Milestone Related to Influenza mRNA Vaccine Program $TBIO https://t.co/HWkL1ucAGo June 8th 2021, 9:06am |
 |
@saVkotpLu4OaAxB $TBIO Reminder: Tomorrow TBIO at $GS Goldman Sachs Healthcare Conference. https://t.co/eswT9OEl7u June 7th 2021, 5:06pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2021. All rights reserved.
DrugPatentWatch Video Training
Decision-making for generic drug entry and branded drug lifecycle management
By tracking patent expirations, patent litigation, generic and biosimilar development, you can anticipate these market-shaping forces and stay one step ahead.
This course answers the following questions to help you adapt:
- ✓ When will key drug patents expire?
- ✓ How can I find, evaluate, and plan for generic market entry opportunities?
- ✓ How can I find proprietary out-of-court settlements and deal terms?